Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2026-02-22 @ 4:52 PM
Study NCT ID:
NCT02234050
Status:
COMPLETED
Last Update Posted:
2025-07-10
First Post:
2014-08-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trabectedin for Recurrent Grade II/III Meningioma
Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Recurrent High Grade Meningioma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Grade 2 Chordoid meningioma | View |
| None | Grade 2 Clear cell meningioma | View |
| None | Grade 2 Atypical meningioma | View |
| None | Grade 3 Papillary meningioma | View |
| None | Grade 3 Rhabdoid meningioma | View |
| None | Grade 3 Anaplastic meningioma | View |
| None | Grade 3 Malignant meningioma | View |